Skip to main content

Book a Meeting

Book a Meeting

Privacy Policy

Consult

Privacy Policy

CTD Conversion

In June 2010, The Medicines Control Council (MCC) announced the intention to implement the South African Common Technical Document (ZA CTD) format which will replace the current MRF1 and any applications still in MBR1 format.

From June 2011, submissions in ZA CTD format are mandatory (excluding veterinary medicines).

Freyr is currently working with many Global Pharmaceutical and Consumer Health Care companies in supporting them in planning and executing the CTD conversion requirement for the existing and new product registrations in South Africa enabling them to meet the MCC mandate.  For some of these global companies CTD conversion is a time consuming and a huge responsibility that needs careful planning and execution given their growing product portfolio in the African market.

Drop us a URL

Privacy Policy

Ebook PDf Download

Get started Now

Privacy Policy

Freyr’s Global Presence

North America

  • Canada - English
  • USA - English
  • Mexico - English

South America

  • Argentina - English
  • Bolivia - English
  • Brazil - English
  • Chile - English
  • Colombia - English
  • Costa Rica - English
  • Dominican Republic - English
  • Ecuador - English
  • French Guiana - English
  • Guatemala - English
  • Guyana - English
  • Panama - English
  • Paraguay - English
  • Peru - English
  • Puerto Rico - English
  • Suriname - English
  • Uruguay - English
  • Venezuela - English

East Europe

  • Kazakhstan - English
  • Kosovo - English
  • Kyrgyzstan - English
  • Serbia - English
  • Tajikistan - English
  • Turkmenistan - English
  • Uzbekistan - English

Europe

  • Albania - English
  • Andorra - English
  • Armenia - English
  • Austria - English
  • Belarus - English
  • Belgium - English
  • Bosnia & Herzegovina - English
  • Bulgaria - English
  • Croatia - English
  • Cyprus - English
  • Czech Republic - English
  • Denmark - English
  • Estonia - English
  • Finland - English
  • France - English
  • Georgia - English
  • Germany - German
  • Greece - English
  • Hungary - English
  • Iceland - English
  • Ireland - English
  • Italy - English
  • Latvia - English
  • Liechtenstein - English
  • Lithuania - English
  • Luxembourg - English
  • Macedonia - English
  • Malta - English
  • Moldova - English
  • Monaco - English
  • Montenegro - English
  • Netherlands - English
  • Norway - English
  • Poland - English
  • Portugal - English
  • Romania - English
  • San Marino - English
  • Slovakia - English
  • Slovenia - English
  • Spain - English
  • Sweden - English
  • Switzerland - English
  • United Kingdom - English
  • Vatican City - English

North Africa & Middle East

  • Algeria - English
  • Bahrain - English
  • Benin - English
  • Burkina Faso - English
  • Burundi - English
  • Cameroon - English
  • Central African Republic - English
  • Chad - English
  • Djibouti - English
  • Egypt - English
  • Eritrea - English
  • Ethiopia - English
  • Gabon - English
  • Gambia - English
  • Ghana - English
  • Guinea - English
  • Guinea Bissau - English
  • Iraq - English
  • Israel - English
  • Ivory Coast - English
  • Jordan - English
  • Kenya - English
  • Kuwait - English
  • Lebanon - English
  • Liberia - English
  • Libya - English
  • Mali - English
  • Mauritania - English
  • Morocco - English
  • Niger - English
  • Nigeria - English
  • Oman - English
  • Palestine - English
  • Qatar - English
  • Rwanda - English
  • Saudi - English
  • Senegal - English
  • Sierra Leone - English
  • Syria - English
  • Togo - English
  • Tunisia - English
  • Turkey - English
  • United Arab Emirates - English
  • Uganda - English
  • Yemen - English

Southern Africa

  • Angola - English
  • Botswana - English
  • Democratic Republic of the Congo - English
  • Lesotho - English
  • Madagascar - English
  • Mauritius - English
  • Malawi - English
  • Mozambique - English
  • Namibia - English
  • Seychelles - English
  • South Africa - English
  • Swaziland - English
  • Tanzania - English
  • Zambia - English
  • Zimbabwe - English

APAC

  • Bangladesh - English
  • Bhutan - English
  • Brunei - English
  • Cambodia - English
  • China - English
  • Fiji - English
  • Hong Kong - English
  • India - English
  • Indonesia - English
  • Laos      - English
  • Malaysia - English
  • Maldives - English
  • Mongolia - English
  • Myanmar - English
  • Nepal   - English
  • Pakistan - English
  • Philippines - English
  • Russia - English
  • Singapore - English
  • Sri Lanka - English
  • Taiwan - English
  • Thailand - English
  • Timor Leste - English
  • Vietnam - English

Australia & New Zealand

  • Australia - English
  • New Zealand - English

Japan & South Korea

  • Japan - English
  • South Korea - English

Good Manufacturing Practice

Good Manufacturing Practice is that part of Quality Assurance which ensures that products are consistently produced and controlled to the quality standards.

  • Regular periodic or rolling quality reviews of all registered medicinal products, including export only products are conducted.
  • The Manufacturer and Holder of Certificate of Registration, where different, should evaluate the results of the review and an assessment should be made of whether corrective and preventative action or any revalidation should be undertaken.

Medicines Control Council’s (MCC)  general policy is that the standard to be used to assess compliance with current Good Manufacturing Practice (cGMP), is the South African Guide to Good Manufacturing Practice (SA guide to GMP).

  • Under Section 22C of the Act, all South African manufacturers should be licensed
  • The Act requires that overseas manufacturers of medicine supplied to South Africa should comply with the same or equivalent manufacturing standards as expected of South African manufacturers
  • When acceptable evidence of GMP compliance is not available, overseas manufacturers are inspected by the GMP Inspectorate before registration of the medicine is approved

Let Us Source

Staffing Requirement for
Industry
Function
Privacy Policy

Medicines Registration

Medicines to be used in South Africa for both public and private sectors shall be duly registered with the national regulatory authority, the Medicines Control Council’s (MCC) in accordance with the provisions and requirements of the Medicines and Related Substances Control Act No. 101 of 1965 and the Regulations and Guidelines published in terms thereof.

A written notification from the Minister to the effect that the medicine is considered essential to national health; an expert report (which is not more than 2 (two) years old; a package insert (where the product has been approved) and a summary basis for the registration (SBRA) should be submitted with application.

The Registrar shall notify the applicant within 30 days of the date of receipt of the application and the Council shall, within 9 months make a decision with regard to the application.

The abbreviated medicine review process is based mainly on the expert reports of the pharmaco toxicological and clinical data.

Applications for Abbreviated Medicine Review Process (AMRP) can only be accepted if the product has been approved by the said authorities within the last three years of the license in the licensing country.

Partner With Us

Country
Privacy Policy

Please fill the form to Download

Privacy Policy

Please fill the form to Download White Paper

Missing webform.

Regulatory Operations

Submissions Publishing

In June 2010, The Medicines Control Council (MCC) announced the intention to implement the South African common technical document (ZA CTD) format which will replace the current MRF1 and any applications still in MBR1 format.  From June 2011, submissions in ZA CTD format are mandatory (excluding veterinary medicines).

With the need for converting old format submissions to CTD format comes the opportunity for Market Authorization Holders (MAH) to plan and be ready for electronic submissions.  Freyr can compile submissions in eCTD format and print in paper format as required by the current MCC requirement. This allows the MAHs to be prepared for future eCTD requirements from MCC and enables efficient electronic submission dossier management.

Registrations and Submissions Information Management

Module 1 (Administrative 1.10 Foreign Regulatory Status) requirement from Medicines Control Council’s (MCC) requires the applicant to provide a list of countries in which an application for the same product is being applied for in South Africa has been submitted, dates of submission (if available). This should detail approvals (with indications).  Applicants must declare whether a marketing application for the medicine has been rejected in the countries listed under 1.10.1 prior to submission of the application in South Africa. If the medicine has been rejected, repeatedly deferred or withdrawn, then the MCC must be informed and the reasons supplied.

If no application has been submitted for registration in the country of origin, include a statement to provide the reason for this decision. It should be noted that aforementioned information is required to be provided in dossier however, it does not mean that this will help to speed up the review process.

Request a Demo

Privacy Policy

Search

 

Contact us

Privacy Policy

Freyr Global Regulatory Solutions and Services

Top Menu

  • Company
    • About Freyr
    • A Decade of Success
    • Awards & Recognitions
    • News
      • Press Releases
      • Freyr In Media
      • Industry Events
    • Testimonials
    • Careers
      • Our Culture
      • Current Openings
    • Compliance Wall
    • Corporate Social Responsibility
  • Insights
    • Blogs
    • Newsletters
      • Quarterly Newsletter
      • Monthly Newsletters
    • Case Studies
    • Webinars
    • White Papers
    • Regulatory Roundup
    • Infographics
    • What is ...?
      • What is Articles
      • What is article podcast
    • Global Health Authority Mandates
    • Brochures
    • Freyr Podcasts
    • e-Books
  • Global Delivery Models
    • Regional / Local Consulting
    • Centralized Functional Outsourcing
    • Hybrid Delivery Models
    • Regulatory Contract Staffing Services
    • Regulatory Centralization
    • Regulatory Program Management and QA
  • Contact Us
    • Locations
    • Partner With Us
  •  
  •  
  •  
    • +1 908 483 7958
    • +44 2037 012379
    • +1 778 308 4671
    • +49 6181 707 9007
    • +52 55 41613365
    • +65 315 894 72
    • +60 39 212 5527
    • +91 40 4848 0999
    • +61 2 8607 5105
    • +41 225 087 129
    • +81 80 5690 1363
  •  
  • sales@freyrsolutions.com
  • Regulatory Affairs
    • Regulatory Services
    • Ai-powered Regulatory Affairs Services
    • Regulatory Consulting/Strategic services
    • Health Authority interactions/Pre-submission meetings
    • Regulatory Submission Road Maps/Regulatory Intelligence Services
    • Dossier Templates for the U.S. and the EU Regulatory Submissions
    • TGA Marketing Authorization Application (MAA)
    • Biologics Registration Services - RoW
    • Regulatory Compliance and Gap Analysis
    • Post-Approval Changes Submissions
    • Lifecycle Management (LCM)
    • Regulatory Staffing Services
    • Clinical Trial Applications (CTAs) For Global Countries
    • Regulatory Affairs Services
    • Brexit-related Regulatory Support
    • Global Health Authorities
    • US FDA Regulatory
    • Abbreviated New Drug Application (ANDA) Submissions
    • Biologics License Applications (BLA)
    • Drug Master File (DMF) Submissions
    • NDA 505 b (1) and 505 b (2)
    • Investigational New Drug (IND) Applications
    • Health Canada Regulatory
    • Abbreviated New Drug Submission (ANDS)
    • New Drug Submission (NDS) for Canada
    • Drug Master File (DMF) Submissions
    • Clinical Trial Applications (CTAs) For Global Countries
    • European HA's
    • Active Substance Master File (ASMF) Submissions
    • Investigational Medicinal Product Dossier (IMPD)
    • EU Marketing Authorization Application (MAA)
    • Certification of Suitability (CEP) Submissions
    • Decentralized Procedure (DCP)
    • Mutual Recognition Procedure (MRP)
    • National Procedure (NP)
    • Centralised Procedure
  • Market Access & Regulatory Intelligence
    • Market Access
      • Product, Market & Regulatory Pathway Strategy
      • Regulatory Strategy for Emerging Markets
    • Regulatory Intelligence Services
      • Drugs Regulatory Intelligence
      • Medical Devices Regulatory Intelligence
      • Cosmetics Regulatory Intelligence
      • Nutraceuticals Regulatory Intelligence
      • Regulatory Market Intelligence Reports
      • Health Authority Directives
      • Ai-powered Regulatory Intelligence Services
    • Freyr Reports
      • Regulatory Intelligence
  • Publishing & Submissions
    Publishing and Submissions
    • Global eCTD Publishing and Submission Services
    • Non-eCTD Electronic Submissions (NeeS)
    • Paper Submissions
    • Legacy Conversions
    • CSR - Report Level Publishing
    • Ai-powered Publishing Automation Services
    • Structure Product Labeling/Monograph (SPL-SPM) Submissions
    • Regulated Product Submissions (RPS)
    • Drug Master File (DMF) Submissions
    • Regulatory/Medical Review of Ad Promo Material
  • Regulatory Labeling
    Regulatory Labeling
    • Clinical Labeling
    • Global Labeling
    • Regional Labeling
      • USA
      • Europe
      • ROW
        • TGA’s New Product Information (PI) Format
    • Pharma Labeling Compliance
    • Medical Device Labeling
    • Food/Dietary Supplements Labeling
    • Ai-powered Regulatory Labelling services
    • Cosmetic Labeling
  • Regulatory Artwork Services
    • Pharmaceuticals
      • Packaging Artwork Process Consulting
      • Artwork Lifecycle Coordination
      • Artwork Management Staffing Services
      • Artwork Management System PLM Tool
      • Artwork Proofreading / Quality Check
      • Artwork RA Labeling
      • Artwork Studio
      • Content to Carton
      • Private Label Artwork
      • Ai-powered Artwork Automation Services
    • Cosmetics

      Creating compliant packaging for a cosmetic product is a collaborative effort of various departments in an organization such as: Labeling, Artwork and Regulatory Affairs. While label artwork must be validated by an artwork labeling team, it must combinedly be reviewed and approved by Regulatory Affairs team to ensure the compliance.

      Read More

    • Food and Food Supplements

      Artwork services for the current Consumer Healthcare/Food Supplements landscapes are divided as per the markets. For Compliance based markets, artworks are created by Freyr team and submitted to the client for finalizing the artwork/ label.

      Read More

    • Medical Devices

      The current medical device landscape has turned challenging for manufacturers in terms of ensuring quality and audit compliance due to ever-evolving regulations which may lead to extended time for approvals and market access.

      Read More

  • Related Regulatory Services
    • Regulatory Medical Writing
      • Promotional Material Review
      • Regulatory/Medical Review of Ad Promo Material
      • Clinical Services
        • Regulatory Writing Services
        • Clinical Trial and Consulting Services
        • Clinical Trial Audit and Monitoring Services
      • Non-clinical Services
        • Nonclinical Regulatory Writing
        • Permitted Daily Exposure (PDE) Calculation
        • Toxicological Risk Assessment (TRA) of Impurities, Extractables & Leachables
      • Scientific Writing
        • Publication Support Services
    • Pharmacovigilance
      • ICSR Services
      • Literature Monitoring Services
      • Aggregate Safety Reports
      • Signal Management
      • Risk Management Pharmacovigilance
      • Pharmacovigilance Audits and Training
      • Pharmacovigilance Safety Database
      • Medical Device Pharmacovigilance
      • Regulatory Intelligence in Pharmacovigilance
      • Quality Control in Pharmacovigilance
    • Compliance, Audit and Validation
      • GxP Audit Services
      • SOP Writing and SOP Review Services
      • Computer System Validation and Computer Software Assurance
      • End-to-End Compliance Services
      • Remote and Virtual Audit
    • Spin-offs, Mergers & Acquisitions, and Divestitures (SoMAD) Consulting services
    • Medical and Scientific Communication
  • Industries / Products
    • Pharmaceuticals
      • Pharmaceuticals Expertise
        • Pharmaceuticals
        • Generics
        • Innovator Drugs
        • CRO
        • CMO
        • Biologics
        • Biosimilars
        • Vaccines
        • Over-the-Counter Drugs
      • Our Presence
        • Australia
        • South Africa
        • South Korea
        • Austria
        • Belgium
        • Brazil
        • Canada
        • China
        • Czech Republic
        • Denmark
        • Egypt
        • France
        • Germany
        • Ireland
        • Italy
        • Japan
        • Malaysia
        • Mexico
        • Netherlands
        • New Zealand
        • Poland
        • Russia
        • Singapore
        • Spain
        • Sweden
        • Turkey
        • UK
        • USA
        • India
        • Nigeria
        • Saudi Arabia
        • Sri Lanka
        • Thailand
    • Medical Devices
      • Medical Devices Expertise
        • Medical Writing
        • Clinical Evaluation Report
        • Post Marketing Surveillance Support
        • Performance Evaluation Report (PER)
        • QMS
        • Quality Management System (QMS) Services
        • ISO 13485:2016 Compliance
        • 21 CFR 820 Compliance
        • Medical Device Single Audit Program (MDSAP)
        • ISO 14971 Risk Management Consulting
        • Design History File
        • Device Documentation
        • Device Technical File Publishing
        • Medical Device Labeling
        • Medical Devices Artwork Services
        • Technical Writing
        • Staff Augmentation
        • Strategy
        • Regulatory Intelligence
        • Translation Support
        • In-country Representation
        • European Authorized Representative (EC REP)
        • US Agent Service
        • Global Authorized Representative
        • UKRP
        • Swiss CH-REP
        • Device Registration in USA
        • 513(g) Submission
        • FDA 510(k) Consulting & Submission
        • Q-Submission Meeting
        • Premarket Approval
        • RFD and Pre-RFD
        • Device Registration in EU
        • In Vitro Diagnostic Regulation (IVDR)
        • EU MDR
        • De-Novo Registration of Medical Devices
        • Medical Device Registration - RoW Market
        • Medical Device Registration in LATAM
        • Device Registrations-SaMD
        • Medical Device Regulatory Consulting
      • Our Presence
        • Americas
        • Canada
        • USA
        • LATAM
        • Brazil
        • Mexico
        • Middle East
        • UAE
        • Saudi Arabia
        • European Union
        • Europe
        • United Kingdom
        • Turkey
        • Singapore
        • Colombia
        • Switzerland
        • Asia Pacific
        • China
        • India
        • Indonesia
        • Japan
        • Malaysia
        • South Korea
        • Australia
        • Taiwan
        • Sri Lanka
        • Vietnam
        • Thailand
        • Africa
        • Nigeria
    • Cosmetics
      • Cosmetics Expertise
        • Cosmetic Product Formulation And Ingredient Review
        • Cosmetic Labeling Review
        • Cosmetics Claims Review
        • Cosmetic Safety Assessment and Toxicology Services
        • Product Information File
        • Go-To-Market and Cosmetics Legal Representative Services
        • Cosmetic Regulatory Intelligence
        • Cosmetics Region-Specific Services
        • Cosmetic Packaging Artwork Solutions
        • Cosmetic Testing Services
        • Brexit-related Regulatory Support
        • Modernization of the Cosmetics Regulation Act of 2022 (MoCRA)
      • Our Presence
        • Australia
        • Brazil
        • Canada
        • China
        • European Union
        • Hong Kong
        • India
        • Indonesia
        • Israel
        • Japan
        • Malaysia
        • Mexico
        • New Zealand
        • Nigeria
        • Philippines
        • Russia
        • Saudi Arabia
        • Singapore
        • South Korea
        • Sri Lanka
        • Thailand
        • UAE
        • United Kingdom
        • USA
        • Vietnam
    • Food and Food Supplements
      • Food and Food Supplements Expertise
        • Claims Consultation and Substantiation
        • Labeling Review
        • Claims Review
        • Dossier Compilation
        • Legal Representation Services
        • Food and Food Supplement Classification
        • Regulatory Intelligence Services
        • Food and Food Supplement Registration
        • Formula Review or Ingredient Assessment
        • Immunity Boosting Supplements
        • NDIN and GRAS (USA/USFDA)
        • Novel Food and Novel Food Ingredient Registration
        • Brexit-related Regulatory Support
        • Alcoholic Beverage Regulatory Compliance
        • GMPs for Dietary Supplements
        • US FDA Food Facility Registration
      • Our Presence
        • Australia
        • Brazil
        • Canada
        • China
        • Colombia
        • European Union
        • France
        • GCC
        • Germany
        • Hong Kong
        • India
        • Italy
        • Indonesia
        • Israel
        • Japan
        • Saudi Arabia
        • Spain
        • Malaysia
        • Mexico
        • New Zealand
        • Nigeria
        • Philippines
        • Peru
        • Poland
        • Russia
        • Singapore
        • Sri Lanka
        • South Africa
        • South Korea
        • Thailand
        • UAE
        • USA
        • United Kingdom
        • Vietnam
    • Chemicals
      • Chemicals Safety and Regulatory Affairs Expertise
        • Chemical Toxicological Risk Assessment
        • Data Scouting Services and Regulatory Intelligence
        • Poison Center, Chemical Registry, Biocidal Notification/Registration
        • Scientific Assessment Reports and Position Paper
        • Supply Chain Regulatory Compliance
        • Chemical Packaging Regulations
        • Ecolabeling Regulatory Support
        • Brexit-related Regulatory Support
        • Chemical Safety Data Sheet
        • Global REACH Regulatory Compliance
        • Turkey REACH Regulatory Compliance
      • Our Presence
        • Australia
        • Brazil
        • China
        • European Union
        • India
        • Indonesia
        • Japan
        • Malaysia
        • Mexico
        • South Africa
        • Saudi Arabia
        • Philippines
        • Singapore
        • South Korea
        • Sri Lanka
        • Thailand
        • UAE
        • USA
        • United Kingdom
  • Regulatory Software & Services
    • Freyr Digital
      • Freyr SUBMIT PRO Publish S.M.A.R.T.
      • Freyr rDMS Regulatory Document Management System
      • Freyr iREADY One-stop Solution for Global Ingredients Regulatory Compliance
      • Freyr IMPACT Regulatory Intelligence Platform
      • Freyr SPL-SPM Structured Product Labeling/ Monograph (SPL-SPM)
      • Freyr SPAR System for Products And Registrations
      • Freyr Artwork 360 End-to-End Artwork - Design. Create. Manage. Automate.
    • RIM Technology & Data Services
      • Master Data Management
        • UDI
      • Regulatory Software Support
        • Quality Assurance
        • Support and Maintenance
  • Global Presence
  • End-to-End Regulatory Services
 

Press Releases

  • Introducing Freyr ARTWORK 360
    An Exclusive Artwork Lifecycle Management Tool

    September 2022

    New Jersey, September 08, 2022: Freyr, one of the largest, global, Regulatory-focused solutions and services providers, as part of its digital transformation drive, introduces Freyr ARTWORK 360 – an exclusive…

    Read More

  • Freyr Successfully Implements its Flagship Submission Tracking software, Freyr SUBMIT Track, for a Leading US-based, Top 20 Global Pharma Company

    September 2022

    New Jersey – Aug 11, 2022: Freyr, one of the largest, global, Regulatory-focused solutions and services companies, announces the implementation of its flagship submission tracking software, Freyr SUBMIT Track, for a leading US-…

    Read More

  • New Project Announcement NDA/MAA Submissions for an Italy-based, Global Pharma Company

    September 2022

    New Jersey, August 17, 2022: Freyr announces a strategic partnership with an Italy-based multinational pharmaceuticals company. The collaboration involves Regulatory support for NDA/MAA submissions.

    Rooting to Freyr’s…

    Read More

  • Freyr Appoints Venkat Luckyreddy as a CISO
    Reinforcing its Commitment and Strengthening its Cybersecurity Resilience

    August 2022

    New Jersey, August 08, 2022 – Freyr announces the appointment of Venkat Luckyreddy as the new Chief Information Security Officer (CISO).

    Read More

  • Freyr Announces a Multi-Year Strategic Partnership with Famar Group
    In Regulatory Submissions & Publishing Software & Services

    August 2022

    New Jersey – Aug 03, 2022: Freyr, one of the largest global Regulatory solutions and services providers, recently announced that Famar – a leading European pharmaceutical manufacturing company with a legacy of 70…

    Read More

  • Gens & Associates Covered Freyr’s Regulatory Information Management Solution Capabilities In its 2022 World Class RIM Research

    July 2022

    New Jersey, July 15, 2022: Freyr Solutions announced that Gens & Associates covered its RIM solution capabilities in their industry standard 2022 World Class RIM Research.

    Read More

  • Freyr IMPACT - Transforming the Regulatory Intelligence EcoSystem Of a Leading, Global Bio-Pharmaceutical Company

    June 2022

    New Jersey, June 13, 2022 - Freyr announced that a leading global Bio-pharmaceutical company selected Freyr IMPACT as its global Regulatory Intelligence (RI) solution to transform their current Regulatory Intelligence ecosystem.

    Read More

  • Freyr Takes a Big Leap with 1000+ Global Regulatory Customers

    May 2022

    New Jersey, May 26, 2022 - Freyr, one of the largest global, Regulatory-focused solutions and services companies for the Life Sciences industry, takes a big leap with 1000+ global Regulatory customers. It is indeed a celebratory…

    Read More

  • Freyr Appoints Poonam Shergill as Vice President - Strategy & Business Growth

    May 2022

    New Jersey, May 11, 2022: Freyr announced the appointment of Poonam Shergill as VP – Strategy and Business Growth, joining Freyr’s global leadership team.

    Read More

  • Freyr Records 300+ PDE and ADE Report Submissions in 2021

    February 2022

    New Jersey, February 16, 2022 - Freyr, one of the largest, global, Regulatory-focused solutions and services companies for the Life Sciences industry is pleased to announce the development of 300+ Permitted Daily Exposure (PDE)…

    Read More

  • Freyr Appoints Praveen Bezawada as the Chief Technology Officer (CTO)

    February 2022

    New Jersey, Feb 15, 2022: Freyr, one of the largest, global, Regulatory-focused solutions and services companies for the Life Sciences industry, announced the appointment of Praveen Bezawada as the Chief Technology Officer (CTO…

    Read More

  • Freyr Completes 10 Successful Years in Business!

    February 2022

    New Jersey, Feb 08, 2022 – Freyr, one of the largest, global, Regulatory-focused solutions and services companies for the Life Sciences industry, announced the successful completion of 10 years in business. With very humble…

    Read More

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page Next ›
  • Last page Last »
Publishing and Submissions
Regulatory Labeling

Creating compliant packaging for a cosmetic product is a collaborative effort of various departments in an organization such as: Labeling, Artwork and Regulatory Affairs. While label artwork must be validated by an artwork labeling team, it must combinedly be reviewed and approved by Regulatory Affairs team to ensure the compliance.

Read More

Artwork services for the current Consumer Healthcare/Food Supplements landscapes are divided as per the markets. For Compliance based markets, artworks are created by Freyr team and submitted to the client for finalizing the artwork/ label.

Read More

The current medical device landscape has turned challenging for manufacturers in terms of ensuring quality and audit compliance due to ever-evolving regulations which may lead to extended time for approvals and market access.

Read More

Global Health Authorities
Regulatory Services

Have a business query? Let’s talk.

Email: sales@freyrsolutions.com or Call: +1 908 483 7958

What We Do

  • Regulatory Affairs
  • Regulatory Labeling
  • Market Access & Regulatory Intelligence
  • Publishing & Submissions
  • Regulatory Artwork Services
  • Regulatory Writing Services
  • Compliance, Audit and Validation
  • Mergers & Acquisitions Consulting
  • Industries/Products
  • Global Presence
  • End-to-End Regulatory Services

Regulatory Software

  • Freyr SUBMIT PRO
  • Freyr rDMS
  • Freyr iREADY
  • Freyr IMPACT
  • Freyr SPL-SPM
  • Freyr SPAR
  • Freyr Artwork 360

Industries

  • Pharmaceuticals
  • Generics
  • Medical Devices
  • Biologics
  • Cosmetics
  • Food and Food Supplements
  • Chemicals
  • Over-The-Counter Drugs

Company

  • About Us
  • Awards and Recognitions
  • Compliance Wall
  • Corporate Social Responsibility
  • Press Releases
  • Freyr in Media
  • Careers
  • Contact Us
  • Partner With Us

Insights

  • Blogs
  • Case Studies
  • Newsletters
  • White Papers
  • Webinars
  • Regulatory Roundup
  • What is ...?
  • Freyr Podcasts

Get in Touch

USA: +1 908 483 7958 / +1 908 409 5626 | Canada: +1 778 308 4671 | Europe: UK +44 203 701 2379 | Germany +49 618 170 79007 | Latin America: Mexico +52 554 161 3365 | Asia Pacific: India +91 40 4848 0999 | Singapore +65 315 89472 | Malaysia +604 222 8860 | Australia +61 2 8607 5105 | South Africa +27 105 002 556

  • Fax +1 866 486 6883
  • Email sales@freyrsolutions.com
  • Linkedin
  • Twitter
  • Facebook
  • Youtube
  • Instagram
Terms of Use | Privacy Policy | Cookie Policy | Customize cookies
© Copyright 2023 Freyr. All Rights Reserved.
Global HA Mandates

Quick Inquiry

Privacy Policy
 
x
  • Regulatory <span>Affairs</span>
    • New Product Authorization - Finished Products
    • New Market Authorizations - APIs
    • Post Approval - CMC and Life Cycle Management
    • Regulatory Assessment | Gap Analysis
    • Regulatory Consulting and Strategy
    • Health Authority Queries – Responses | Interactions
    • Market Authorization Application (MAA) - Article 10 (1)
    • MAA - Post-Approval Submissions
    • MAA - License Renewal
    • Investigational Medicinal Product Dossiers (IMPD)
    • Biosimilars MAA – Article 10(4)
    • Active Substance Master File (ASMF) Submissions
    • Certification of Suitability (CEP) Submissions
    • Sister CEP Submissions
    • Brexit-related Regulatory Support
    • Dossier Templates for USFDA and EU Regulatory Submissions
  • Market Access & <span>Regulatory Intelligence </span>
    • Market Access
      • Product, Market & Regulatory Pathway Strategy
      • Strategic Regulatory Services – Africa
      • Regulatory Strategy for Emerging Markets
    • Regulatory Intelligence
      • Drugs Regulatory Intelligence
      • Medical Devices Regulatory Intelligence
      • Nutraceuticals Regulatory Intelligence
      • Regulatory Market Intelligence Reports
      • Health Authority Directives
    • Freyr Reports
      • Regulatory Intelligence
  • Publishing & <span>Submissions</span>
    • Global eCTD Publishing and Submission Services
    • NeeS Submissions
    • Paper Submissions
    • Legacy Conversions
    • CSR - Report Level Publishing
    • Structure Product Labeling/Monograph (SPL-SPM) Submissions
    • Regulated Product Submissions (RPS)
    • Drug Master File (DMF) Submissions
    • Regulatory/Medical Review of Ad Promo Material
  • Regulatory <span>Labeling</span>
    • Clinical Labeling
    • Global Labeling
    • Regional Labeling
      • USA
      • Europe
      • ROW
        • TGA’s New Product Information (PI) Format
    • Labeling Compliance
    • Medical Devices Labeling
    • Food/Dietary Supplements Labeling
  • Regulatory<span> Artwork Services</span>
    • Pharmaceuticals
      • Packaging Artwork Process Consulting
      • Artwork Lifecycle Coordination
      • Artwork Management Staffing Services
      • Artwork Management System PLM Tool
      • Artwork Proofreading / Quality Check
      • Artwork RA Labeling
      • Artwork Studio
      • Content to Carton
    • Cosmetics
    • Food and Food Supplements
    • Medical Devices
  • Related <span>Regulatory Services</span>
    • Regulatory Medical Writing
      • Regulatory/Medical Review of Ad Promo Material
      • Clinical Services
        • Regulatory Writing Services
        • Clinical Trial and Consulting Services
        • Clinical Trial Audit and Monitoring Services
      • Non-clinical Services
        • Nonclinical Regulatory Writing
        • Permitted Daily Exposure (PDE)
        • Toxicological Risk Assessment (TRA)
      • Scientific Writing
      • Manuscript Writing and End-to-End Services
    • Pharmacovigilance
      • ICSR Services
      • Literature Monitoring Services
      • Aggregate Safety Reports
      • Signal Management
      • Risk Management
      • PV Audit and Training
      • Pharmacovigilance Safety Database
      • Medical Device PMS/Vigilance
      • Regulatory Intelligence and Consulting in Pharmacovigilance
      • Quality Control
    • Compliance, Audit and Validation
      • GxP Audit Services
      • SOP Writing and SOP Review Services
      • Computer System Validation and Computer System Assurance
      • End-to-End Compliance Services
      • Remote and Virtual Audit
    • Spin-offs, Mergers & Acquisitions, and Divestitures (SoMAD) Consulting services
  • Industries / <span>Products</span>
    • Pharmaceuticals
      • Pharmaceuticals Expertise
        • Pharmaceuticals
        • Generics
        • Innovator Drugs
        • CRO
        • CMO
        • Biologics
        • Biosimilars
        • Vaccines
        • Over-The-Counter Drugs
      • Our Presence
        • Australia
        • Austria
        • Belgium
        • Brazil
        • Canada
        • China
        • Czech Republic
        • Denmark
        • Egypt
        • France
        • Germany
        • Ireland
        • Italy
        • Japan
        • Malaysia
        • Mexico
        • Netherlands
        • New Zealand
        • Poland
        • Russia
        • Singapore
        • Spain
        • Sweden
        • Turkey
        • UK
        • USA
        • India
        • Nigeria
        • Saudi Arabia
        • Sri Lanka
        • Thailand
    • Medical Devices
      • Medical Devices Expertise
        • UKRP
        • European Authorized Representative (EAR)
        • US Agent Service
        • Authorized Representative
        • Labeling & Promotional Material Review
        • Post Market Surveillance Support
        • QMS Compliance Services
        • Regulatory Compliance, Gap Analysis & Remediation
        • Regulatory Intelligence
        • Regulatory Strategy
        • Regulatory Submission and Registration
        • Translation
        • 510(k) Submission Process Consulting
        • 513(g) Submission Process Consulting
      • Our Presence
        • Brazil
        • India
        • Netherlands
        • Nigeria
        • Saudi Arabia
        • Switzerland
    • Cosmetics
      • Cosmetics Expertise
        • Safety Assessment and Toxicology
        • Formulation Review and Product Classification
        • Cosmetics Claims and Substantiation
        • Labeling Review
        • Cosmetics Packaging Artwork Solutions
        • Product Information / Technical File Compilation
      • Our Presence
        • Nigeria
        • Singapore
        • Thailand
        • Brazil
        • China
        • Israel
        • New Zealand
        • Russia
        • Sri Lanka
        • UAE
        • UK
        • Vietnam
    • Food and Food Supplements
      • Food and Food Supplements Expertise
        • Formulation Review and Product Classification
        • Nutraceuticals Claims Review
        • Product Labeling Review
        • Technical Documents/ Dossier Compilation
        • Freyr iREADY - Ready to Use Ingredients Database
      • Our Presence
        • China
        • Brazil
        • GCC
        • Indonesia
        • Hong Kong
        • Israel
        • Kingdom of Saudi Arabia
        • Mexico
        • Malaysia
        • Nigeria
        • Philippines
        • Russia
        • Singapore
        • South Korea
        • USA
        • Srilanka
        • Thailand
        • UAE
        • United Kingdom
  • Regulatory <span>Software & Services</span>
    • Freyr Digital
      • Freyr SUBMIT PRO
      • Freyr rDMS
      • Freyr iREADY
      • Freyr IMPACT
      • Freyr SPL-SPM
      • Freyr SPAR
    • RIM Technology & Data Services
      • Master Data Management
        • UDI
      • Regulatory Software Support
        • Quality Assurance
        • Support and Maintenance
  • Global <span>Presence</span>
  • End-to-end <span>Regulatory Services</span>
  • Home